Zim Laboratories

Zim_Laboratories26 Apr 2024

Pharmaceuticals

₹

-1.92 (-1.55%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Zim Laboratories

Zim Laboratories

Pharmaceuticals

Zim_Laboratories26 Apr 2024

₹

-1.92 (-1.55%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
22-May-2019	D	Zim Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 22, 2019, inter alia, has recommended Dividend at the rate of Rs. 0.50 per share for the financial year 2018-19.	19-Sep-2019
14-Aug-2018	D	Zim Laboratories Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on August 14, 2018, inter alia, has approved the following: Recommendation of 10% final Dividend on equity shares of Rs. 10/- each i.e. Re 1/- per equity share, for the year ended March 31, 2018.	03-Sep-2018
12-Dec-2022	B	2:1 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, ZIM Laboratories Limited has fixed the Record Date for the purpose of Bonus Issue. The transactions in the Equity Shares of the Company would be on an Ex-Bonus basis with effect from the under mentioned date : DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE ZIM Laboratories Limited (541400) RECORD DATE 22/12/2022 PURPOSE Issue of 2 (Two) Bonus Equity Shares of Rs.10/- each for every 1 (One) existing Equity Share of Rs.10/- each held. Ex-Bonus basis from Date & Sett. No. 22/12/2022 DR-682/2022-2023 (As Per BSE Notice Dated on 19.12.2022)	22-Dec-2022	2:1
28-Sep-2018	B	Trading Members of the Exchange are hereby informed that, Zim Laboratories Limited has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Zim Laboratories Limited (541400) RECORD DATE 06/10/2018 PURPOSE Issue of 01 (One) Bonus equity share of Rs.10/- each for every 01 (One) existing equity share of Rs.10/- each held. Ex-Bonus basis from Date & Sett. No. 04/10/2018 DR-130/2018-2019 Trading Members of the Exchange are requested to take of it.	06-Oct-2018	1:1
01-Apr-2024	BC	Mathew Cyriac	27-Mar-2024
22-Jan-2024	BC	Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve the unaudited Financial Results (Standalon	29-Jan-2024
28-Dec-2023	BC	Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 please find enclosed a copy of the Postal Ballot notice dated 23rd December 2023 along with explanatory statement for seeking approval of mem	28-Jan-2024
20-Dec-2023	BC	Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/12/2023 inter alia to consider and approve the ZIM Laboratories Employee Stock Option	23-Dec-2023
09-Nov-2023	BC	Mathew Cyriac	07-Nov-2023

No Rights has been declared by Zim_Laboratories

Book Closure

Record Date	Split Date	Purpose
27-Mar-2024	-	Mathew Cyriac
29-Jan-2024	-	Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve the unaudited Financial Results (Standalon
28-Jan-2024	01 Jan'1900	Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 please find enclosed a copy of the Postal Ballot notice dated 23rd December 2023 along with explanatory statement for seeking approval of mem
23-Dec-2023	-	Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/12/2023 inter alia to consider and approve the ZIM Laboratories Employee Stock Option
07-Nov-2023	-	Mathew Cyriac

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Zim Laboratories Ltd ₹122.29(-1.92/-1.55%)	122.29	-1.92	595.87	54.35	37.28	2.72
Astrazeneca Pharma India Ltd ₹5,415.40(+81.55/1.53%)	5,415.40	+81.55	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹122.60(+5.85/5.01%)	122.60	+5.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,409.40(+4.00/0.28%)	1,409.40	+4.00	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹25,864.85(+201.35/0.78%)	25,864.85	+201.35	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹680.85(-8.80/-1.28%)	680.85	-8.80	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	95.82	85.26	67.01	104.45	100.32	99.26
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	95.82	85.26	67.01	104.45	100.32	99.26
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.11	1.42	0.63	0.70	2.42	1.44
Total Income	96.93	86.68	67.64	105.15	102.74	100.70
Total Expenditure	84.64	76.30	62.47	89.40	87.68	87.14
PBIDT	12.28	10.38	5.17	15.75	15.06	13.56
Interest	1.70	1.22	1.73	1.27	1.62	1.36
PBDT	10.59	9.17	3.44	14.48	13.44	12.20
Depreciation	3.58	3.72	3.66	4.58	3.56	4.04
Tax	1.30	0.82	0.00	1.62	1.84	1.49
Deferred Tax	0.88	0.45	-0.08	1.14	1.48	1.01
Reported Profit After Tax	4.83	4.18	-0.14	7.14	6.57	5.66
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	4.83	4.18	-0.14	7.14	6.57	5.66

EPS (Unit Curr.)	0.99	0.86	-0.03	1.46	1.35	3.49
EPS (Adj) (Unit Curr.)	0.99	0.86	-0.03	1.46	1.35	1.16
Calculated EPS (Unit Curr.)	0.99	0.86	-0.03	1.47	1.35	3.48
Calculated EPS (Adj) (Unit Curr.)	0.99	0.86	-0.03	1.47	1.35	1.16
Calculated EPS (Ann.) (Unit Curr.)	3.97	3.43	-0.12	5.86	5.39	13.93
Calculated EPS (Adj) (Ann.) (Unit Curr.)	3.97	3.43	-0.12	5.86	5.39	4.64
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	48.73	48.73	48.73	48.73	48.73	16.24
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	12.82	12.17	7.72	15.08	15.01	13.66
PBDTM(%)	11.05	10.76	5.13	13.86	13.40	12.29
PATM(%)	5.04	4.90	-0.21	6.84	6.55	5.70

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	96.29	85.83	67.44	105.41	100.97	99.40
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	96.29	85.83	67.44	105.41	100.97	99.40
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.11	1.42	1.12	0.69	2.40	1.42
Total Income	97.40	87.25	68.56	106.11	103.37	100.82
Total Expenditure	84.76	76.50	62.61	89.96	87.88	87.14
PBIDT	12.65	10.75	5.95	16.14	15.50	13.68
Interest	1.70	1.22	1.73	1.27	1.62	1.36
PBDT	10.95	9.53	4.21	14.87	13.88	12.32
Depreciation	3.94	4.09	4.03	4.93	3.90	4.37
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	1.35	0.84	0.04	1.56	1.90	1.49
Deferred Tax	0.88	0.45	-0.08	1.14	1.48	1.01
Reported Profit After Tax	4.78	4.15	0.23	7.24	6.60	5.45
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	4.78	4.15	0.23	7.24	6.60	5.45

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	4.78	4.15	0.23	7.24	6.60	5.45

EPS (Unit Curr.)	0.98	0.85	0.05	1.48	1.35	3.35
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	48.73	48.73	48.73	48.73	48.73	16.24

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	13.14	12.52	8.82	15.31	15.35	13.76
PBDTM(%)	11.37	11.10	6.24	14.11	13.75	12.39
PATM(%)	4.96	4.84	0.34	6.87	6.54	5.48

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	48.73	16.24	16.24	16.18	16.12	8.06
Reserves Total	145.45	153.86	140.81	135.57	135.10	127.91
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	194.18	170.10	157.05	151.75	151.22	135.97
Secured Loans	59.57	51.31	81.07	89.44	74.18	75.83
Unsecured Loans	2.59	2.13	1.25	0.41	3.02	5.32
Total Debt	62.16	53.44	82.32	89.85	77.20	81.15
Total Liabilities	256.34	223.54	239.37	241.60	228.42	217.12
APPLICATION OF FUNDS :
Gross Block	192.04	174.12	159.53	153.14	130.16	112.90
Less : Accumulated Depreciation	84.89	70.82	56.38	41.90	29.39	18.74
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	107.15	103.30	103.15	111.24	100.77	94.16
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	26.26	11.42	10.46	9.62	13.32	8.29
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	8.18	8.18	8.08	8.08	4.54	0.09
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	53.71	75.28	54.35	56.39	55.05	51.56
Sundry Debtors	88.36	80.89	63.95	63.34	90.40	88.34
Cash and Bank	2.21	2.09	7.86	2.83	2.81	3.52
Loans and Advances	34.37	42.33	56.81	53.73	42.99	28.62
Total Current Assets	178.64	200.60	182.97	176.29	191.25	172.05
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	73.13	108.74	79.51	79.58	92.01	79.90
Provisions	0.59	2.78	1.40	1.06	4.42	0.43
Total Current Liabilities	73.72	111.52	80.91	80.64	96.44	80.32
Net Current Assets	104.92	89.08	102.06	95.66	94.81	91.73
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	4.22	9.15	11.46	15.11	13.86	15.56
Deferred Tax Liability	9.03	9.51	8.92	9.78	11.78	11.89
Net Deferred Tax	-4.81	-0.36	2.54	5.33	2.08	3.67
Total Assets	241.70	211.63	226.29	229.93	215.52	197.94
Contingent Liabilities	6.67	6.98	6.05	5.89	5.14	5.88

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	48.73	16.24	16.24	16.18	16.12	8.06
Reserves Total	151.62	159.47	144.51	137.64	135.00	128.54
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	200.35	175.71	160.75	153.82	151.12	136.60
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	59.57	51.31	81.07	89.44	74.18	75.83
Unsecured Loans	2.59	2.13	1.25	0.41	3.02	5.32
Total Debt	62.16	53.44	82.32	89.85	77.20	81.15
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.00	0.00	0.00	0.63	0.00	0.00
Total Liabilities	262.51	229.15	243.07	244.30	228.32	217.75
APPLICATION OF FUNDS :
Gross Block	198.66	180.24	165.49	159.23	135.67	112.90
Less: Accumulated Depreciation	90.01	74.60	58.97	43.31	29.66	18.74
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	108.65	105.64	106.52	115.92	106.01	94.16
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	26.99	11.75	10.68	9.62	13.32	8.29
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.05	0.05	0.05	0.05	0.05	0.05
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	53.71	75.28	54.35	56.39	55.05	51.56
Sundry Debtors	95.25	89.52	72.25	67.93	93.10	89.22
Cash and Bank	7.52	4.97	8.35	3.95	2.94	3.53
Loans and Advances	34.48	42.36	56.81	53.76	43.00	28.63
Total Current Assets	190.95	212.14	191.76	182.03	194.09	172.94
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	73.67	109.34	80.31	79.95	95.71	80.11
Provisions	0.59	2.78	1.40	1.06	4.42	0.43
Total Current Liabilities	74.27	112.12	81.71	81.01	100.13	80.54
Net Current Assets	116.68	100.01	110.04	101.02	93.96	92.40
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	4.22	9.15	11.53	15.11	13.86	15.56
Deferred Tax Liability	9.03	9.51	8.92	9.78	11.78	11.89
Net Deferred Tax	-4.81	-0.36	2.61	5.33	2.08	3.67
Other Assets	14.93	12.06	13.16	12.35	12.91	19.17
Total Assets
Contingent Liabilities	6.67	6.98	6.05	5.89	5.14	5.88

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.54	0.90	0.67	0.36	1.46
Net Cash from Operating Activities	35.23	47.03	31.90	21.29	37.08
Net Cash Used In Investing Activities	-35.21	-14.42	-5.70	-18.82	-23.03
Net Cash Used In Financing Activities	0.55	-32.97	-25.96	-2.16	-15.16
Net Inc./Dec In Cash And Cash Equivalents	0.57	-0.36	0.23	0.31	-1.10
Cash And Cash Equivalents At End Of The Year	1.11	0.54	0.90	0.67	0.36

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

33.26%

FII Shareholding

0.01%

DII Shareholding

0.00%

Public Shareholding

66.73%

**Promoter pledged shareholding 33.26%

About Zim Laboratories Ltd

Zim Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 595.87 crores. It has reported a sales of Rs. 95.82 crores and a net profit of Rs. 4.83 crores for the quarter ended December 2018. The company management includes Anwar S Daud, Anwar S Daud,Zulfiquar M Kamal,Prakash Sapkal,Niraj Dhadiwal,Kavita Loya,Padmakar Joshi,Piyush Nikhadi,Kamlesh Shende,Kakasaheb Mahadik (Zim Laboratories Ltd) among others.

Chairman

Anwar S Daud

Registered office

Sadoday Gyan (Gr Floor),Opp NADT Nelson Square,Nagpur,Maharashtra,440013

FAX :

Background

Incorporation Year1984

Face Value₹10

Market Lot1

How to buy Zim Laboratories shares on nse?

To buy Zim Laboratories shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Zim Laboratories share price today?

The Zim Laboratories shares price on nse is Rs.122.29 today.

What is the market cap of Zim Laboratories shares on BSE ?

The company has a market capitalization of Rs.595.87Cr

What is the PE & PB ratio of Zim Laboratories shares ?

PE is 37.28 and PB is 2.72

What is the 52 Week High and Low of Zim Laboratories shares?

Zim Laboratories stock price high: Rs.151.75 Zim Laboratories stock price low: Rs.74